Melatonin receptor expression in rat cerebral artery

Neuroscience Letters

Volumn 341, Issue 3, 2003, Pages 259-261

  Chucharoen, Prapapun ^a   Chetsawang, Banthit ^a   Srikiatkhachorn, Anan ^b   Govitrapong, Piyarat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Alzheimer; Cerebral artery; Hypothalamus; Melatonin receptor; Migraine; Pineal gland

Indexed keywords

MELATONIN RECEPTOR; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; BRAIN ARTERY; BRAIN REGION; CONTROLLED STUDY; GENE AMPLIFICATION; HYPOTHALAMUS; MALE; MOLECULAR BIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PINEAL BODY; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 0037426567     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00214-3     Document Type: Article

References (20)

1. Brun J., Claustrat B., Saddier P., Chazot G. Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses. Cephalalgia. 15:1995;136-139.
2. 2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins. Cell Signalling. 14:2002;249-257.
3. Doolen S., Krause D.N., Dubocovich M.L., Duckles S.P. Melatonin mediates two distinct responses in vascular smooth muscle. Eur. J. Pharmacol. 345:1998;67-69.
4. Fiorina P., Lattuada G., Ponari O., Silvestrini C., DallAglio P. Impaired nocturnal melatonin excretion and changes of immunological status in ischaemic stroke patients. Lancet. 347:1996;692-693.
5. Geary G.G., Krause D.N., Duckles S.P. Melatonin directly constricts rat cerebral arteries through modulation of potassium channels. Am. J. Physiol. 273:1997;H1530-H1536.
6. Hong K.W., Pyo K.M., Lee W.S., Yu S.S., Rhim B.Y. Pharmacological evidence that calcitonin gene-related peptide is implicated in cerebral autoregulation. Am. J. Physiol. 266:1994;H11-H16.
7. Krause D.N., Dubocovich M.L. Melatonin receptors. Annu. Rev. Pharmacol. Toxicol. 31:1991;549-568.
8. 2 melatonin receptors. J. Pineal Res. 30:2001;171-179.
9. Lotufo C.M., Lopes C., Dubocovich M.L., Farsky S.H., Markus R.P. Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation. Eur. J. Pharmacol. 430:2001;351-357.
10. 125I]iodo-5-methoxycarbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites. Eur. J. Pharmacol. 301:1996;159-168.
11. Pappolla M.A., Chyan Y.J., Poeggeler B., Frangione B., Wilson G., Ghiso J., Reiter R.J. An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. J. Neural. Transm. 107:2000;203-231.
12. 1 melatonin receptor mRNA expression exhibits a circadian variation in the rat suprachiasmatic nuclei. Brian Res. 946:2002;64-71.
13. Roca A.L., Godson C., Weaver D.R., Reppert S.M. Structure, characterization, and expression of the gene encoding the mouse Mel1a melatonin receptor. Endocrinology. 137:1996;3469-3477.
14. Regrigny O., Delagrange P., Scalbert E., Atkinson J., Lartaud-Idjouadiene A. Melatonin improves cerebral circulation security margin in rats. Am. J. Physiol. 275:1998;H139-H144.
15. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12:1991;151-180.
16. Reppert S.M., Godson C., Mahle C.D., Weaver D.R., Slaugenhaupt S.A., Gusella J.F. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc. Natl. Acad. Sci. USA. 92:1995;8734-8738.
17. Reppert S.M., Weaver D.R., Cassone V.M., Godson C., Kolakowski L.F. Melatonin receptors are for the birds: molecular analysis of two receptor subtypes differentially expressed in chick brain. Neuron. 15:1995;1003-1015.
18. 1-receptor alterations in patients with Alzheimer's disease. Neurosci. Lett. 308:2001;9-12.
19. 1 melatonin receptor subtype in the tail artery of juvenile Wistar rats. Br. J. Pharmacol. 127:1999;987-995.
20. Viswanathan M. Melatonin inhibits calcitonin gene-related peptide-induced vasodilation and increase in cAMP in rat middle cerebral arteries. Eur. J. Pharmacol. 415:2001;247-250.